CA
Can-Fite BioPharma Ltd.
CANF · AMEX
$2.28 +1.79% (+$0.04)
1M -33.13%
Market Cap $2.96M
P/E Ratio -
Div. Yield -
ROE 201.06%
Piotroski F-Score Weak
2/9Valuation
56 /100
Fair P/S 7.31x
P/B 0.53x
P/E N/A
Growth
15 /100
Declining Rev. growth 20.42%
Book val. growth 7.73%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 100.00%
FCF margin 2,210.12%
Net margin 2,426.67%
Quality
1 /100
Poor ROIC 145.49%
Asset turnover 0.04x
ROE 201.06%
Debt
100 /100
Low Debt/Equity 0.01x
Current ratio 3.46x
Int. coverage N/A
Stability
20 /100
Unstable Beta 0.02x
Profitable years 0
Rev. volatility 17.71%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o CANF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Motti Farbstein
Employees
5
Headquarters
Ramat Gan
Prihajajoči dogodki
01 APR.
Earnings
Upcoming earnings report